Rise in global prevalence of blood disorders, increase in number of road accidents and surgeries, and surge in global geriatric population are driving the demand for safe transfusion blood.
Transfusion blood undergoes thorough screening before it is transfused into a recipient’s bloodstream owing to the susceptibility of transfusion incompatibility. Numerous infections can be transmitted by transfusion of blood. Therefore, it is critical to examine collected / donated blood carefully before transfusion.
Blood transfusion diagnostics play a significant role in ensuring donor-recipient compatibility and screening of infections that might be present in blood.
Numerous players are engaged in offering innovative new-generation solutions. The surge in collaborations and partnerships between healthcare entities and research institutions aimed at broadening adoption of blood transfusion diagnostics contributes significantly to market expansion.
Blood transfusion diagnostics are immunohematology tests that are required prior to transfusion of whole blood or blood products such as red blood cells, therapeutic plasma, and platelets.
The devices are available in two major types: the instruments for continuous loading and unloading of samples where analytical tests can be performed and results can be recorded; and kits and reagents. Kits and reagents are the repetitive units required for conducting the tests.
The various pre-transfusion tests that are conducted using blood transfusion diagnostics to ensure blood safety includes ABO blood typing, Rh typing, extended phenotyping, RBC antibody screening, as well as serological and molecular disease screening.
As manufacturers are constantly innovating to improve product capabilities, high-throughput analytical instruments are being introduced for better workflow efficiency.
The need for blood is poised to increase at a rapid rate, ascribed to the surge in cases of blood disorders, and the increase in number of surgeries and accidents. The blood transfusion diagnostics industry growth is assured owing to its critical role in ensuring safety of transfusion blood and blood products.
| Attribute | Detail |
|---|---|
| Drivers |
|
Multiple blood-related disorders require patients to undergo blood transfusions frequently, thereby driving the demand for safe transfusion blood. The surge in prevalence of blood-related disorders such as leukemia, thalassemia, sickle cell anemia, and hemophilia is driving the blood transfusion diagnostics market growth.
According to the Leukemia and Lymphoma Society, in 2023, an estimated 59,610 new leukemia cases were diagnosed in the U.S, while 23,710 deaths are estimated to be attributed to leukemia.
The World Health Organization (WHO) estimates that 5% of the world population are carriers of trait genes for hemoglobin disorders, specifically thalassemia and sickle cell anemia. These statistics suggest that every year, over 300,000 infants are born with severe hemoglobin disorders.
Technological innovations in blood donor management systems have brought about significant changes in the industry. The emergence of automated systems has streamlined workflows, making them more efficient and error-free. An important technology that has impacted the industry is donor recruitment and engagement.
Companies have introduced cutting-edge software and mobile applications, which have enabled information to reach potential donors, helping in improving the overall donor engagement by scheduling appointments, sending reminders, and offering post-donation care instructions, thus improving the overall donor experience and enhancing donor retention rate.
Furthermore, advanced management systems and cloud-based technologies have enabled secure storage and easy retrieval of donor information, improving traceability from donor to recipient, and thus offering lucrative blood transfusion diagnostics market opportunities.
The blood transfusion diagnostics market segmentation based on product type includes instruments, and kits and reagents.
Prior to blood transfusion, collected blood samples are screened for blood typing, compatibility, and transfusion transmissible infection screening. All of these tests require kits and reagents, driving the growth of the segment. Additionally, these products are affordable and easily available in the market.
As per the blood transfusion diagnostics market analysis, based on end-user, the market is classified into blood banks, blood donation / transfusion centers, and others.
Blood banks are expected to hold lucrative market share during the forecast period. In majority of settings, pre-transfusion testing of donated blood is conducted in blood banks. As the demand for safe transfusion blood increases, blood banks play a key role in ensuring the supply of infection-free blood to patients in need.
Further, the increasing number of disease screening tests required for ensuring safety of blood before transfusion is also fueling the growth of this segment.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest blood transfusion diagnostics market forecast, North America held dominant share in 2023. Advancement of healthcare infrastructure, increase in awareness, and augmented healthcare finances are driving market dynamics in the region.
In the U.S., several companies are launching innovative transfusion diagnostics solutions to augment their market position. For instance, in March 2024, Roche received U.S. FDA approval for its cobas Malaria test for use on the cobas 6800/8800 Systems. The diagnostic test is intended to reduce potential risk of malarial infection from transfused blood products.
In the European Union, sickle cell anemia is considered a rare disease, affecting 5 in 10,000 individuals. However, prevalence of the disease is rising in the EU due to global population movements.
Therefore, medical device manufacturers and the EU government are taking appropriate actions to improve transfusion blood availability in the region, driving the blood transfusion diagnostics market share of Europe.
Over the years, Asia Pacific has seen a notable increase in the proportion of geriatric population. Concurrently, the demand for blood is likely to rise due to the surge in prevalence of several disorders.
Expansion of the blood transfusion diagnostics market in Asia Pacific at the highest CAGR is ascribed to the steep increase in major blood-related disorders in countries such as Japan, India, and China.
The market in Asia Pacific is anticipated to be driven by an increase in number of device approvals, rise in adoption of automated instruments for diagnostics, and entry of multinational firms within the marketplace.
The blood transfusion diagnostics market is fragmented with the presence of a number of players. Emerging players in the blood transfusion diagnostics market include Grifols, S.A., Werfen, Ortho Clinical Diagnostics, Abbott, Bio-Rad Laboratories Inc., F. Hoffman La Roche Ltd., AliveDx, BAG Diagnostics GmbH, Diasorin S.p.A., Prestige Diagnostics, Atlas Medical, and Lorne Laboratories
Each of these players have been have been profiled in the blood transfusion diagnostics market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2023 | US$ 4.6 Bn |
| Forecast Value in 2034 | More than US$ 7.7 Bn |
| CAGR - 2024-2034 | 4.9% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2023 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 4.6 Bn in 2023
It is projected to reach more than US$ 7.7 Bn by the end of 2034
The CAGR is anticipated to be 4.9% from 2024 to 2034
North America is expected to account for largest share from 2024 to 2034
Grifols, S.A., Werfen S.A., QuidelOrtho Corporation, Abbott, Bio-Rad Laboratories Inc., F. Hoffman La Roche Ltd., AliveDx Holdings Finance Company Ltd, BAG Diagnostics GmbH, Diasorin S.p.A., Prestige Diagnostics U.K. Ltd., Atlas Medical GmbH, and Lorne Laboratories Limited
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Blood Transfusion Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Epidemiology of Blood Disorders and Prevalence of Blood Transfusion Events
5.2. Blood Transfusion Products Pricing Analysis
5.3. Government Procurement Policies of Blood Transfusion Diagnostics
5.4. Key Industry Events (Partnerships, Collaborations, Product Approvals, Mergers and Acquisitions, Funding and investments)
5.5. Impact of COVID-19 Pandemic
6. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2020-2034
6.3.1. Instruments
6.3.1.1. Blood Grouping Instruments
6.3.1.2. Others
6.3.2. Kits and Reagents
6.3.2.1. Blood Grouping Kits and Reagents
6.3.2.2. Others
6.4. Market Attractiveness By Product Type
7. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2020-2034
7.3.1. Blood Grouping
7.3.1.1. ABO Blood Grouping
7.3.1.2. Rh Blood Grouping
7.3.1.3. Red Blood Cell Antibody Screening
7.3.1.4. Extended Phenotyping
7.3.1.5. Cross Matching Tests
7.3.2. Disease Screening
7.3.2.1. Molecular Disease Screening
7.3.2.2. Serological Disease Screening
7.4. Market Attractiveness By Application
8. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2020-2034
8.3.1. Blood Banks
8.3.2. Blood Donation / Transfusion Centers
8.3.3. Others
8.4. Market Attractiveness By End-user
9. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Blood Transfusion Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product Type, 2020-2034
10.2.1. Instruments
10.2.1.1. Blood Grouping Instruments
10.2.1.2. Others
10.2.2. Kits and Reagents
10.2.2.1. Blood Grouping Kits and Reagents
10.2.2.2. Others
10.3. Market Value Forecast By Application, 2020-2034
10.3.1. Blood Grouping
10.3.1.1. ABO Blood Grouping
10.3.1.2. Rh Blood Grouping
10.3.1.3. Red Blood Cell Antibody Screening
10.3.1.4. Extended Phenotyping
10.3.1.5. Cross Matching Tests
10.3.2. Disease Screening
10.3.2.1. Molecular Disease Screening
10.3.2.2. Serological Disease Screening
10.4. Market Value Forecast By End-user, 2020-2034
10.4.1. Blood Banks
10.4.2. Blood Donation / Transfusion Centers
10.4.3. Others
10.5. Market Value Forecast By Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Blood Transfusion Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2020-2034
11.2.1. Instruments
11.2.1.1. Blood Grouping Instruments
11.2.1.2. Others
11.2.2. Kits and Reagents
11.2.2.1. Blood Grouping Kits and Reagents
11.2.2.2. Others
11.3. Market Value Forecast By Application, 2020-2034
11.3.1. Blood Grouping
11.3.1.1. ABO Blood Grouping
11.3.1.2. Rh Blood Grouping
11.3.1.3. Red Blood Cell Antibody Screening
11.3.1.4. Extended Phenotyping
11.3.1.5. Cross Matching Tests
11.3.2. Disease Screening
11.3.2.1. Molecular Disease Screening
11.3.2.2. Serological Disease Screening
11.4. Market Value Forecast By End-user, 2020-2034
11.4.1. Blood Banks
11.4.2. Blood Donation / Transfusion Centers
11.4.3. Others
11.5. Market Value Forecast By Country, 2020-2034
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country
12. Asia Pacific Blood Transfusion Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2020-2034
12.2.1. Instruments
12.2.1.1. Blood Grouping Instruments
12.2.1.2. Others
12.2.2. Kits and Reagents
12.2.2.1. Blood Grouping Kits and Reagents
12.2.2.2. Others
12.3. Market Value Forecast By Application, 2020-2034
12.3.1. Blood Grouping
12.3.1.1. ABO Blood Grouping
12.3.1.2. Rh Blood Grouping
12.3.1.3. Red Blood Cell Antibody Screening
12.3.1.4. Extended Phenotyping
12.3.1.5. Cross Matching Tests
12.3.2. Disease Screening
12.3.2.1. Molecular Disease Screening
12.3.2.2. Serological Disease Screening
12.4. Market Value Forecast By End-user, 2020-2034
12.4.1. Blood Banks
12.4.2. Blood Donation / Transfusion Centers
12.4.3. Others
12.5. Market Value Forecast By Country, 2020-2034
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country
13. Latin America Blood Transfusion Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2020-2034
13.2.1. Instruments
13.2.1.1. Blood Grouping Instruments
13.2.1.2. Others
13.2.2. Kits and Reagents
13.2.2.1. Blood Grouping Kits and Reagents
13.2.2.2. Others
13.3. Market Value Forecast By Application, 2020-2034
13.3.1. Blood Grouping
13.3.1.1. ABO Blood Grouping
13.3.1.2. Rh Blood Grouping
13.3.1.3. Red Blood Cell Antibody Screening
13.3.1.4. Extended Phenotyping
13.3.1.5. Cross Matching Tests
13.3.2. Disease Screening
13.3.2.1. Molecular Disease Screening
13.3.2.2. Serological Disease Screening
13.4. Market Value Forecast By End-user, 2020-2034
13.4.1. Blood Banks
13.4.2. Blood Donation / Transfusion Centers
13.4.3. Others
13.5. Market Value Forecast By Country, 2020-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country
14. Middle East & Africa Blood Transfusion Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2020-2034
14.2.1. Instruments
14.2.1.1. Blood Grouping Instruments
14.2.1.2. Others
14.2.2. Kits and Reagents
14.2.2.1. Blood Grouping Kits and Reagents
14.2.2.2. Others
14.3. Market Value Forecast By Application, 2020-2034
14.3.1. Blood Grouping
14.3.1.1. ABO Blood Grouping
14.3.1.2. Rh Blood Grouping
14.3.1.3. Red Blood Cell Antibody Screening
14.3.1.4. Extended Phenotyping
14.3.1.5. Cross Matching Tests
14.3.2. Disease Screening
14.3.2.1. Molecular Disease Screening
14.3.2.2. Serological Disease Screening
14.4. Market Value Forecast By End-user, 2020-2034
14.4.1. Blood Banks
14.4.2. Blood Donation / Transfusion Centers
14.4.3. Others
14.5. Market Value Forecast By Country, 2020-2034
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Company Profiles
15.2.1. Grifols, S.A.
15.2.1.1. Company Overview
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Business Strategies
15.2.1.5. Recent Developments
15.2.2. Werfen, S.A.
15.2.2.1. Company Overview
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Business Strategies
15.2.2.5. Recent Developments
15.2.3. QuidelOrtho Corporation
15.2.3.1. Company Overview
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Business Strategies
15.2.3.5. Recent Developments
15.2.4. Abbott
15.2.4.1. Company Overview
15.2.4.2. Financial Overview
15.2.4.3. Product Portfolio
15.2.4.4. Business Strategies
15.2.4.5. Recent Developments
15.2.5. Bio-Rad Laboratories Inc.
15.2.5.1. Company Overview
15.2.5.2. Financial Overview
15.2.5.3. Product Portfolio
15.2.5.4. Business Strategies
15.2.5.5. Recent Developments
15.2.6. F. Hoffman La Roche Ltd.
15.2.6.1. Company Overview
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Business Strategies
15.2.6.5. Recent Developments
15.2.7. AliveDx Holdings Finance Company Ltd
15.2.7.1. Company Overview
15.2.7.2. Financial Overview
15.2.7.3. Product Portfolio
15.2.7.4. Business Strategies
15.2.7.5. Recent Developments
15.2.8. BAG Diagnostics GmbH
15.2.8.1. Company Overview
15.2.8.2. Financial Overview
15.2.8.3. Product Portfolio
15.2.8.4. Business Strategies
15.2.8.5. Recent Developments
15.2.9. Diasorin S.p.A.
15.2.9.1. Company Overview
15.2.9.2. Financial Overview
15.2.9.3. Product Portfolio
15.2.9.4. Business Strategies
15.2.9.5. Recent Developments
15.2.10. Prestige Diagnostics U.K. Ltd.
15.2.10.1. Company Overview
15.2.10.2. Financial Overview
15.2.10.3. Product Portfolio
15.2.10.4. Business Strategies
15.2.10.5. Recent Developments
15.2.11. Atlas Medical GmbH
15.2.11.1. Company Overview
15.2.11.2. Financial Overview
15.2.11.3. Product Portfolio
15.2.11.4. Business Strategies
15.2.11.5. Recent Developments
15.2.12. Lorne Laboratories Limited
15.2.12.1. Company Overview
15.2.12.2. Financial Overview
15.2.12.3. Product Portfolio
15.2.12.4. Business Strategies
15.2.12.5. Recent Developments
List of Tables
Table 01: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Type, 2020-2034
Table 02: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instrument, 2020-2034
Table 03: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
Table 04: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 05: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
Table 06: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
Table 07: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 08: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Region, 2020-2034
Table 09: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 10: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
Table 11: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
Table 12: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
Table 13: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 14: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
Table 15: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
Table 16: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
Table 19: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
Table 20: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
Table 21: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 22: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
Table 23: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
Table 24: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 25: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 26: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
Table 27: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
Table 28: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
Table 29: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 30: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
Table 31: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
Table 32: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 33: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 34: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
Table 35: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
Table 36: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
Table 37: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 38: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
Table 39: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
Table 40: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 41: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 42: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
Table 43: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Instruments, 2020-2034
Table 44: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Kits and Reagents, 2020-2034
Table 45: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Application, 2020-2034
Table 46: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Blood Grouping, 2020-2034
Table 47: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by Disease Screening, 2020-2034
Table 48: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Blood Transfusion Diagnostics Market Value Share, by Product Type, 2023
Figure 03: Global Blood Transfusion Diagnostics Market Value Share, by Application, 2023
Figure 04: Global Blood Transfusion Diagnostics Market Value Share, by End-user, 2023
Figure 05: Global Blood Transfusion Diagnostics Market Value Share, by Region, 2023
Figure 06: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
Figure 07: Global Blood Transfusion Diagnostics Market Share Analysis, by Product Type, 2023
Figure 08: Global Blood Transfusion Diagnostics Market Share Analysis, by Product Type, 2034
Figure 09: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 10: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Instruments, 2020‒2034
Figure 11: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Instruments, 2023 and 2034
Figure 12: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Kits and Reagents, 2020‒2034
Figure 13: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Kits & Reagents, 2023 and 2034
Figure 14: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
Figure 15: Global Blood Transfusion Diagnostics Market Share Analysis, by Application, 2023
Figure 16: Global Blood Transfusion Diagnostics Market Share Analysis, by Application, 2034
Figure 17: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
Figure 18: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Blood Grouping, 2020‒2034
Figure 19: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Blood Grouping, 2023 and 2034
Figure 20: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Disease Screening, 2020‒2034
Figure 21: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Disease Screening, 2023 and 2034
Figure 22: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 23: Global Blood Transfusion Diagnostics Market Share Analysis, by End-user, 2023
Figure 24: Global Blood Transfusion Diagnostics Market Share Analysis, by End-user, 2034
Figure 25: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 26: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Blood Banks, 2020‒2034
Figure 27: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Blood Banks, 2023 and 2034
Figure 28: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Hospitals, 2020‒2034
Figure 29: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Hospitals, 2023 and 2034
Figure 30: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Blood Donation / Transfusion Centers, 2020‒2034
Figure 31: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Blood Donation / Transfusion Centers, 2023 and 2034
Figure 32: Global Blood Transfusion Diagnostics Market Value (US$ Mn), by Others, 2020‒2034
Figure 33: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Others, 2023 and 2034
Figure 34: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Region, 2023 and 2034
Figure 35: Global Blood Transfusion Diagnostics Market Share Analysis, by Region, 2023
Figure 36: Global Blood Transfusion Diagnostics Market Share Analysis, by Region, 2034
Figure 37: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Region, 2023-2034
Figure 38: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 39: North America Blood Transfusion Diagnostics Market Value Share Analysis, by Country, 2023 and 2034
Figure 40: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country, 2024-2034
Figure 41: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
Figure 42: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 43: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
Figure 44: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
Figure 45: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 46: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 47: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 48: Europe Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 49: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 50: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
Figure 51: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 52: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
Figure 53: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
Figure 54: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 55: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 56: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 57: Asia Pacific Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 58: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 59: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
Figure 60: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 61: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
Figure 62: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
Figure 63: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 64: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 65: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 66: Latin America Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 67: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 68: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
Figure 69: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 70: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
Figure 71: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
Figure 72: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 73: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 74: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 75: Middle East & Africa Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 76: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 77: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Product Type, 2023 and 2034
Figure 78: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2024-2034
Figure 79: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
Figure 80: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2024-2034
Figure 81: Middle East & Africa Blood Transfusion Diagnostics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
Figure 82: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Blood Transfusion Diagnostics Market
